Iatrogenic botulism following cosmetic botulinum toxin injection treated with delayed antitoxin therapy

Documenti analoghi

• Statement of the Rehabilitation Medicine Society of Australia and New Zealand for the therapeutic use of botulinum toxin A in spasticity management
  di: Anupam Datta Gupta, et al.
  Pubblicazione: (2024)
• Depression following the initiation of glucagon‐like‐peptide‐1 receptor agonist therapy: A multinational self‐controlled case series study
  di: Vincent Ka Chun Yan, et al.
  Pubblicazione: (2026)
• Cerebellar stroke secondary to ovarian stimulation and patent foramen ovale
  di: Owen Ka Lung Chan, et al.
  Pubblicazione: (2025)
• Short course antiviral therapy to prevent donor‐derived hepatitis C virus infection
  di: Peter Boan, et al.
  Pubblicazione: (2025)
• Multidisciplinary management of intermediate and high‐risk pulmonary embolism in the era of mechanical thrombectomy: a local practice guideline
  di: Anna Dunn, et al.
  Pubblicazione: (2025)